Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia

Gut

Volumn 44, Issue 3, 1999, Pages 424-429

  Cramp, M E ^a   Carucci, P ^a   Rossol, S ^c   Chokshi, S ^a,b   Maertens, G ^d   Williams, R ^a,b   Naoumov, N V ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c Department of Gastroenterology ^*  (Germany)

^d INNOGENETICS   (Belgium)

Author keywords

Hepatitis C virus; Liver; T helper cytokines; Th1 Th2 cells; Viral clearance

Indexed keywords

GAMMA INTERFERON; HEPATITIS C ANTIBODY; VIRUS PROTEIN; VIRUS RNA;

ADULT; AGED; ARTICLE; CELLULAR IMMUNITY; CLEARANCE; CYTOKINE PRODUCTION; FEMALE; HELPER CELL; HEPATITIS C; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VIREMIA;

EID: 0032985725     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.44.3.424     Document Type: Article

References (37)

1. van der Poel CL, Cuypers HT, Reesink HW. Hepatitis C virus six years on. Lancet 1994;344:1475-9.
2. Alter HJ. To C or not to C: these are the questions. Blood 1995;85:1681-95.
3. Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team [see comments]. N Engl J Med 1992;327:1899-905.
4. Cory-Cantilena C, VanRaden M, Gibble J, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus liver infection. N Engl J Med 1996; 344:1691-6.
5. Botarelli P, Brunetto MR, Minutello MA, et al. T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology 1993;104: 580-7.
6. Hoffmann RM, Diepolder HM, Zachoval R, et al. Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection. Hepatology 1995;21:632-8.
7. Rehermann B, Chang KM, McHutchison JG, et al. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J Clin Invest 1996;98:1432-40.
8. Battegay M, Fikes J, Di Bisceglie AM, et al. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. J Virol 1995;69:2462-70.
9. Alter HJ, Purcell RH, Shih JW, et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989;321:1494-500.
10. Farci P, Alter HJ, Wong DC, et al. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci USA 1994;91: 7792-6.
11. Lai ME, Mazzoleni AP, Argiolu F, et al. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet 1994;343:388-90.
12. Farci P, Alter HJ, Govindarajan S, et al. Lack of protective immunity against reinfection with hepatitis C virus. Science 1992;258:135-40.
13. Mosmann TR, Cherwinski H, Bond MW, et al. Two types of murine helper T cell clone. 1. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-57.
14. Del Prete G, Maggi E, Romagnani S. Human Th1 and Th2 cells: functional properties, mechanisms of regulation, and role in disease. Lab Invest 1994;70:299-306.
15. Clerici M, Shearer GM. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol Today 1994;15:575-81.
16. Yamamura M, Uyemura K, Deans RJ, et al. Defining protective responses to pathogens: cytokine profiles in leprosy lesions [published correction appears in Science 1992; 255:12]. Science 1991;254:277-9.
17. Sher A, Gazzinelli RT, Oswald IP, et al. Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection. Immunol Rev 1992;127:183-204.
18. Diepolder HM, Zachoval R, Hoffmann RM, et al. Possible mechanism involving T-lymphocyte response to nonstructural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 1995;346:1006-7.
19. Missale G, Bertoni R, Lamonaca V, et al. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest 1996;98:706-14.
20. Gerken G, Pontisso P, Roggenorf M, et al. Clinical evaluation of a single reaction, diagnostic polymerase chain reaction assay for the detection of hepatitis C virus RNA. J Hepatol 1996;24:33-7.
21. Marinos G, Torre F, Chokshi S, et al. Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus. Hepatology 1995;22:1040-9.
22. Rossol S, Voth R, Laubenstein HP, et al. Interferon production in patients infected with HFV-1. J Infect Dis 1989;159: 815-21.
23. Lechmann M, Ihlenfeldt H, G., Braunschweiger I, et al. T and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus-positive blood donors without viremia. Hepatology 1996;24:790-5.
24. Rehermann B, Ferrari C, Pasquinelli C, et al. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 1996;2:1104-8.
25. Penna A, Artini M, Cavalli A, et al. Long-lasting memory T cell responses following self-limited acute hepatitis B. J Clin Invest 1996;98:1185-94.
26. Michalak TI, Pasquinelli C, Guilhot S, et al. Hepatitis B virus persistence after recovery from acute viral hepatitis. J Clin Invest. 1994;93:230-9.
27. Haydon GH, Jarvis LM, Blair CS, et al. Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection. Gut 1998;42:570-5.
28. Schlesinger JJ, Brandriss MW, Cropp CB, et al. Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1. J Virol 1986;60; 1153-5.
29. Rumenapf T, Stark R, Meyers G, et al. Structural proteins of hog cholera virus expressed by vaccinia virus: further characterization and induction of protective immunity. J Virol 1991;65:589-97.
30. Farci P, Shimoda A, Wong D, et al. Prevention of HCV infection in chimpanzees by hyperimmune serum against the hypervariable region 1 (HVR1): emergence of neutralization escape mutants in vivo [abstract]. Hepatology 1995;22:220A.
31. Yuki N, Hayashi N, Kasahara A, et al. Quantitative analysis of antibody to hepatitis C virus envelope 2 glycoprotein in patients with chronic hepatitis C virus infection. Hepatology 1996;23:947-52.
32. Maertens G, Barlet V, Zarski J-P, et al. Prognosis of long-term resolvement from hepatitis C virus infection by E1 antibody monitoring [abstract]. Hepatohgy 1995;22: 355A.
33. Minutello MA, Pileri P, Unutmaz D, et al. Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C. J Exp Med 1993; 178:17-25.
34. Thursz MR, Kwiatkowski D, Allsopp CE, et al. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med 1995;332:1065-9.
35. Cramp ME, Carucci P, Underhill J, et al. Association between HLA Class II genotype and spontaneous clearance of HCV infection. J Hepatol 1998;29:207-13.
36. McDonnell WM, Askari FK. Molecular medicine series: DNA vaccines. N Engl J Med 1996;334:42-5.
37. Boyer JD, Ugen KE, Wang B, et al. Protection of chimpanzees from high-dose heterologous HFV-1 challenge by DNA vaccination. Nat Med 1997;3:526-32.